You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指曾飆逾500點 港交所、潤啤、紫金及藥明生物漲約4.5%-8.5%
美國最新通脹及核心通脹顯降至27個月及廿個月低兼低預期,市場憧憬美聯儲即7月後或將完結加息周期。此外,人民幣兌美元中間價連續第五天上調,今天上調238點,報7.1527。港股四連升兼今天跑贏區內及歐美市場,恆指升破50天線(19,284),最多急漲505點,高見19,366(暫受制250天線19,378),現報19,329,急漲468點或2.5%,總成交額增至557億元。 80隻藍籌除潤電(00836.HK)及信義玻璃(00868.HK)逆跌近1%外,全部造好,升幅普遍逾1%-3%;國壽(02628.HK)、中國平安(02318.HK)及權重金融股友邦(01299.HK)升2%-3%,後者跑贏,股價重越10天、20天及50天線,最高見81.15元。權重之一匯控(00005.HK)升1.2%報62.15元。 港交所(00388.HK)四連升兼曾重越50天線(303.9元),最高見304.6元,現報303.4元,急漲4.4%。 新經濟股以美團(03690.HK)升幅最大,股價突破百天線(131.5元),最高見135元,現報134.9元,急漲6%。騰訊(00700.HK)、阿里(09988.HK)、百度(09888.HK)及京東(09618.HK)續升2.5%-4.7%,後兩者跑贏,最高見147.9元及148.5元,現報146.8元及148.3元,續升3.4%及4.7%。 藥明生物(02269.HK)重越10天及20天線,最高見41.45元,現報40.7元,急彈8.5%。阿里健康(00241.HK)及京東健康(06618.HK)追漲近7%-9%,報5.2元及55.9元。 美匯指數昨晚挫逾1%至100.51創15個月低,貼金價漲的紫金(02899.HK)升破百天線(12.34元),最高見12.92元,現報12.68元‧,漲5.8%。內需股以潤啤(00291.HK)最強,股價曾重越10天及20天線(50.8元),最高見51.05元,現報50.65元,漲5%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account